Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients (Q44255432)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients |
scientific article |
Statements
1 reference
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients (English)
1 reference
M Untch
1 reference
M P Lux
1 reference
M Schmidt
1 reference
N Harbeck
1 reference
M Schmitt
1 reference
C Meisner
1 reference
C Friedel
1 reference
C G J Sweep
1 reference
B W Lisboa
1 reference
T Beck
1 reference
S Hasmüller
1 reference
M Kiechle
1 reference
F Jänicke
1 reference
C Thomssen
1 reference
Chemo-N 0 Study Group
1 reference
13 March 2013
1 reference
1 reference
49
1 reference
8
1 reference
1825-1835
1 reference
Identifiers
1 reference
1 reference